Piper Sandler raised the firm’s price target on Eastman Chemical to $105 from $90 and keeps a Neutral rating on the shares following Q1 results and updated guidance for the remainder of the year. The firm cites better-than-expected Q1 earnings and a somewhat more robust outlook for the industry and the end markets Eastman is tied to.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMN: